IGRO - ETF AI Analysis

Top Page

iShares International Dividend Growth ETF (IGRO)

Rating:65Neutral

Price Target:―

The iShares International Dividend Growth ETF (IGRO) has a solid overall rating, driven by strong contributions from holdings like Novartis AG and Roche Holding AG. Novartis stands out with its robust profitability, stable balance sheet, and growth in key products, while Roche benefits from strong cash flow management and strategic initiatives in pharmaceuticals. However, some holdings, such as Iberdrola and Enel S.p.A., face challenges like high debt levels and slower revenue growth, which may slightly weigh on the fund's overall performance. A key risk factor for IGRO is its exposure to companies with potential overbought conditions, which could lead to short-term volatility.

Positive Factors

Strong Top Holdings

Several of the largest positions, such as Nestlé and Roche, have delivered strong year-to-date performance, supporting the ETF's overall returns.

Global Diversification

The ETF invests across multiple countries, including Japan, Switzerland, and Canada, reducing reliance on any single economy.

Low Expense Ratio

The fund charges a very low expense ratio, making it cost-effective compared to many other ETFs.

Negative Factors

Sector Concentration in Financials

The ETF has significant exposure to the financial sector, which could amplify risks if this sector experiences a downturn.

Mixed Performance Among Holdings

Some top holdings, such as Sanofi, have shown weaker year-to-date performance, potentially dragging on overall returns.

Limited U.S. Exposure

With only about 10% of assets in U.S. companies, the ETF may miss out on opportunities in the world's largest economy.

IGRO vs. SPDR S&P 500 ETF (SPY)

AUM1.12B

RegionGlobal Ex-U.S.

Expense Ratio0.15%

Beta0.51

IssueriShares

Inception DateMay 17, 2016

Dividend Yield2.5%

Asset ClassEquity

Index TrackedMorningstar Global ex-US Dividend Growth

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume63,313

30 Day Avg. Volume103,847

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

89.35

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering462

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

IGRO Summary

The iShares International Dividend Growth ETF (IGRO) is an investment fund that focuses on companies outside the U.S. with a strong history of increasing dividends. It follows the Morningstar Global ex-US Dividend Growth index and includes well-known companies like Nestlé and Roche. This ETF is ideal for investors looking to diversify globally while benefiting from steady income and potential growth. However, new investors should know that its performance depends on international markets, which can be affected by currency fluctuations and global economic conditions.

How much will it cost me?The iShares International Dividend Growth ETF (IGRO) has an expense ratio of 0.15%, which means you’ll pay $1.50 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking an index of international dividend growth companies.

What would affect this ETF?The iShares International Dividend Growth ETF (IGRO) could benefit from global economic recovery and increased demand for dividend-paying stocks, especially in sectors like financials, healthcare, and utilities, which make up a significant portion of its holdings. However, potential risks include currency fluctuations, geopolitical tensions, and slower economic growth in international markets, which could negatively impact the performance of its top holdings and overall portfolio. Changes in interest rates or regulatory policies in key regions could also influence the ETF's future returns.

IGRO Top 10 Holdings

The iShares International Dividend Growth ETF (IGRO) leans heavily into financials, with names like Toronto Dominion Bank and Royal Bank of Canada driving strong recent performance thanks to bullish momentum and resilient earnings. Healthcare giants Roche and Novartis also provide steady growth, bolstered by robust pipelines and shareholder-friendly policies. However, consumer staples leader Nestlé has been lagging slightly, and Sanofi’s mixed performance suggests some headwinds in the pharmaceutical space. With a global ex-U.S. focus, IGRO offers a diversified play on international dividend growth, though its concentration in financials and healthcare may leave it vulnerable to sector-specific risks.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
NOVN	Novartis AG	3.06%	$34.19M	CHF209.54B	25.57%	80 Outperform
ROG	Roche Holding AG	2.97%	$33.16M	CHF263.28B	52.00%	73 Outperform
NESN	Nestlé SA	2.95%	$32.98M	CHF196.70B	18.81%	71 Outperform
	―	2.88%	$32.16M	―	―	―
RY	Royal Bank Of Canada	2.82%	$31.49M	$239.63B	41.55%	75 Outperform
BATS	British American Tobacco	2.72%	$30.36M	£91.66B	46.35%	71 Outperform
7203	Toyota Motor	2.66%	$29.71M	¥44.51T	20.98%	80 Outperform
TD	Toronto Dominion Bank	2.45%	$27.38M	$159.26B	77.36%	74 Outperform
SAN	Sanofi	2.24%	$25.02M	€99.59B	0.35%	75 Outperform
IBE	Iberdrola	2.06%	$22.97M	€120.37B	39.79%	67 Neutral

IGRO Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

80.51

Positive

100DMA

79.49

Positive

200DMA

76.96

Positive

Market Momentum

MACD

0.69

Negative

RSI

66.52

Neutral

STOCH

88.25

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IGRO, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 81.63, equal to the 50-day MA of 80.51, and equal to the 200-day MA of 76.96, indicating a bullish trend. The MACD of 0.69 indicates Negative momentum. The RSI at 66.52 is Neutral, neither overbought nor oversold. The STOCH value of 88.25 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IGRO.

IGRO Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
IGRO	―	―	$1.12B	0.15%	―
VIGI	―	―	$9.03B	0.10%	―
CGXU	―	―	$4.50B	0.54%	―
CWI	―	―	$2.28B	0.30%	―
ILOW	―	―	$1.55B	0.50%	―
APIE	―	―	$967.53M	0.45%	―

Performance Comparison

IGRO

iShares International Dividend Growth ETF

83.11

16.52

24.81%

VIGI

Vanguard International Dividend Appreciation ETF

―

CGXU

Capital Group International Focus Equity ETF

―

CWI

SPDR MSCI ACWI ex-US ETF

―

ILOW

AB International Low Volatility Equity ETF

―

APIE

ActivePassive International Equity ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents